North Carolina HB 328: Central Carolina Community College Funds.

Bill Text

GENERAL ASSEMBLY OF NORTH CAROLINA
SESSION 2025
H 4
HOUSE BILL 328
Committee Substitute Favorable 3/25/25
Committee Substitute #2 Favorable 4/8/25
Senate Health Care Committee Substitute Adopted 6/17/25

Short Title: Regulate Hemp-Derived Consumables. (Public)
Sponsors:
Referred to:
March 10, 2025
*H328-v-4*
A BILL TO BE ENTITLED 1
AN ACT TO REGULATE THE SALE, DISTRIBUTION, AND POSSESSION OF 2
HEMP-DERIVED CONSUMABLE PRODUCTS AND TO ADD KRATOM AS A 3
SCHEDULE VI CONTROLLED SUBSTANCE. 4
The General Assembly of North Carolina enacts: 5
6
PART I. REGULATE HEMP-DERIVED CONSUMABLE PRODUCTS 7
SECTION 1.(a) The General Statutes are amended by adding a new Chapter to read: 8
"Chapter 18D. 9
"Regulation of Hemp-Derived Consumable Products. 10
"Article 1. 11
"Regulation of Hemp-Derived Consumable Products. 12
"§ 18D-100. Definitions. 13
Unless the context requires otherwise, the following definitions apply in this Chapter: 14
(1) ALE Division. – The Alcohol Law Enforcement Division of the Department 15
of Public Safety. 16
(2) Batch. – The hemp-derived consumable product produced during a period of 17
time under similar conditions and identified by a specific code that allows 18
traceability. 19
(3) Distributor. – A person or entity that delivers or sells hemp-derived 20
consumable products for the purpose of distribution in commerce. 21
(4) Exit package. – An opaque bag or other similar opaque covering provided at 22
the point of sale that satisfies the child-resistant effectiveness standards under 23
16 C.F.R. § 1700.15(b)(1) when tested in accordance with the requirements 24
of 16 C.F.R. § 1700.20 in which hemp-derived consumable products are 25
placed by a seller after being sold to the ultimate consumer of the product. 26
(5) Hemp. – As defined in G.S. 90-87. 27
(6) Hemp-derived cannabinoid. – Any phytocannabinoid found in hemp, 28
including delta-9 tetrahydrocannabinol (delta-9 THC), tetrahydrocannabinolic 29
acid (THCA), cannabidiol (CBD), cannabidiolic acid (CBDA), cannabinol 30
(CBN), cannabigerol (CBG), cannabichromene (CBC), cannabicyclol (CBL), 31
cannabivarin (CBV), tetrahydrocannabivarin (THCV), cannabidivarin 32
(CBDV), cannabicitran (CBT), delta-7 tetrahydrocannabinol (delta-7 THC), 33
delta-8 tetrahydrocannibinol (delta-8 THC), or delta-10 tetrahydrocannibinol 34

General Assembly Of North Carolina Session 2025
Page 2 House Bill 328-Fourth Edition
(delta-10 THC). This term also includes any synthetic cannabinoid derived 1
from hemp and contained in a hemp-derived consumable product. 2
(7) Hemp-derived consumable product. – A hemp product that is a finished good 3
intended for human ingestion or inhalation that at the time of sale to the 4
ultimate consumer contains a delta-9 THC concentration of not more than 5
three-tenths of one percent (0.3%) on a dry weight basis. This term does not 6
include hemp products intended for topical application, or seeds or 7
seed-derived ingredients that are generally recognized as safe by the United 8
States Food and Drug Administration (FDA). 9
(8) Hemp product. – As defined in G.S. 90-87. 10
(9) Independent testing laboratory. – A laboratory that meets all of the following 11
conditions: 12
a. Holds an ISO 17025 accreditation or is registered with the Drug 13
Enforcement Administration (DEA) in accordance with 21 C.F.R. § 14
1301.13. 15
b. Does not have a direct or indirect interest in the entity whose product 16
is being tested. 17
c. Does not have a direct or indirect interest in a facility that cultivates, 18
processes, distributes, dispenses, or sells hemp-derived consumable 19
products, or prohibited hemp-derived consumable products in this 20
State or any other jurisdiction. 21
d. Has entered into a compliance agreement with the ALE Division to 22
conduct tetrahydrocannabinol concentration sampling and testing 23
using the high-performance chromatography (HPLC) testing method. 24
(10) Ingestion. – The process of consuming hemp through the mouth, by 25
swallowing into the gastrointestinal system or through tissue absorption. 26
(11) Inhalation. – The process of consuming hemp into the respiratory system 27
through the mouth or nasal passages. 28
(12) License. – A license issued in accordance with this Chapter. 29
(13) Licensee. – A person who has been issued a license in accordance with this 30
Chapter. 31
(14) Manufacture. – To compound, blend, extract, infuse, cook, or otherwise 32
manipulate hemp or a hemp-derived cannabinoid to make, prepare, or package 33
hemp-derived consumable products. 34
(15) Manufacturer. – Any person or entity that engages in the process of 35
manufacturing, preparing, or packaging of hemp-derived consumable 36
products. 37
(16) Producer. – Any person or entity licensed to grow hemp by the United States 38
Department of Agriculture that engages in the process of farming and 39
harvesting hemp that is intended to be used in the manufacture of a 40
hemp-derived consumable product. 41
(17) Prohibited hemp-derived consumable product. –